Valuation Strides Pharma Science Limited

Stocks

Market Closed - NSE India S.E. 15:05:10 16/10/2026 +04			5-day change	1st Jan Change
1,045.20 ^INR	-1.39%		-3.69%	+16.09%

08-19	Strides Pharma Science Limited Receives USFDA Establishment Inspection Report for Bengaluru Facility	CI
08-13	Vintage Classic Limited and Ascent Capital Advisors India Private Limited acquired 65.05% stake in Pivot Path Private Limited from Strides Pharma Science Limited for INR 1.0 billion.	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	31,121	25,858	72,114	61,675	86,435	96,339	-
Change	-	-16.91%	178.88%	-14.47%	40.15%	11.46%	-
Enterprise Value (EV)	31,121	25,858	72,114	61,675	86,435	96,339	96,339
Change	-	-16.91%	178.88%	-14.47%	40.15%	11.46%	0%
P/E	-6.76x	-12.7x	-101x	1.71x	15.5x	15.3x	11x
PBR	1.32x	1.19x	3.39x	-	2.78x	2.6x	2.14x
PEG	-	0.2x	1.5x	-0x	-0.2x	1.2x	0.3x
Capitalization / Revenue	1.01x	0.7x	1.78x	1.35x	1.78x	1.65x	1.39x
EV / Revenue	0x	0x	0x	0x	0x	1.65x	1.39x
EV / EBITDA	-0x	0x	0x	0x	0x	8.62x	6.87x
EV / EBIT	-0x	0x	0x	-	0x	10.9x	8.81x
EV / FCF	-0x	-0x	0x	0x	0x	20x	14.7x
FCF Yield	-12.9%	-1.95%	8.08%	7.16%	3.29%	4.99%	6.81%
Dividend per Share ²	-	1.5	2.5	-	5	3	3
Rate of return	-	0.52%	0.32%	-	0.53%	0.29%	0.29%
EPS ²	-51.28	-22.49	-7.76	390.5	60.34	68.1	95.4
Distribution rate	-	-6.67%	-32.2%	-	8.29%	4.41%	3.14%
Net sales ¹	30,702	36,884	40,511	45,653	48,587	58,230	69,123
EBITDA ¹	-103.2	4,302	7,433	8,028	9,253	11,173	14,014
EBIT ¹	-2,531	1,869	5,226	-	7,229	8,850	10,940
Net income ¹	-4,602	-2,026	-706.1	35,935	5,562	6,277	8,798
Net Debt	-	-	-	-	-	-	-
Reference price ²	346.60	286.35	784.70	669.20	937.75	1,045.20	1,045.20
Nbr of stocks (in thousands)	89,790	90,303	91,900	92,163	92,173	92,173	-
Announcement Date	24/05/22	25/05/23	22/05/24	22/05/25	18/05/26	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
STRIDES PHARMA SCIENCE LIMITED	15.35x	-	-	0.29%	1.02B
ELI LILLY AND COMPANY	35.96x	12.96x	27.14x	0.55%	1,120B
JOHNSON & JOHNSON	37.4x	6.3x	17.74x	2.09%	616B
ABBVIE INC.	36.43x	8.36x	17.24x	2.43%	504B
ROCHE HOLDING AG	20.46x	4.99x	12.38x	2.64%	367B
MERCK & CO., INC.	106.52x	5.95x	25.12x	2.33%	360B
NOVARTIS AG	21.18x	5.54x	13.63x	2.88%	288B
ASTRAZENECA PLC	21.7x	4.38x	12.55x	2.01%	258B
AMGEN INC.	27.46x	7.06x	12.64x	2.33%	234B
GILEAD SCIENCES, INC.	-45.63x	6.99x	27.07x	2.11%	194B
Average	27.68x	6.95x	18.39x	1.97%	394.19B
Weighted average by Cap.	34.72x	8.20x	20.04x	1.84%